Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells

KRZYSZTOF KOTOWSKI, STANISŁAW SUPPLITT, DANIEL WICZEW, DAWID PRZYSTUPSKI, WERONIKA BARTOSIK, JOLANTA SACZKO, JOANNA ROSSOWSKA, MAŁGORZATA DRĄG-ZALESIŃSKA, OLGA MICHEL and JULITA KULBACKA
Anticancer Research May 2020, 40 (5) 2613-2625; DOI: https://doi.org/10.21873/anticanres.14232
KRZYSZTOF KOTOWSKI
1Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STANISŁAW SUPPLITT
2Department of Genetics, Wroclaw Medical University, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL WICZEW
3Faculty of Fundamental Problems in Technology, Wroclaw University of Science and Technology, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAWID PRZYSTUPSKI
1Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WERONIKA BARTOSIK
4Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOLANTA SACZKO
5Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOANNA ROSSOWSKA
6Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAŁGORZATA DRĄG-ZALESIŃSKA
7Department of Human Morphology and Embryology, Division of Histology and Embryology, Wroclaw Medical University, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLGA MICHEL
5Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JULITA KULBACKA
5Department of Molecular and Cellular Biology, Wroclaw Medical University, Wroclaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: julita.kulbacka@umed.wroc.pl
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    The schematic presentation of the molecular basis of targeting PFKFB3 as a therapeutic strategy against melanoma (A) (Adapted from Ref. 19) and (B) the 2D structure of 3PO (20). EGR: Epidermal growth factor; EGFR: epidermal growth factor receptor; HIF-1α: hypoxia-inducible factor α; Fru-2,6-BP: fructose 2,6-bisphosphate; F-1,6-BP: fructose 1,6-bisphosphate; PFK-1: phosphofructokinase-1; PFKFB3: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3; DHA: dihydroxyacetone: G3P: glyceraldehyde 3-phosphate.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Simulation of the 3PO binding efficacy: A) docking of the 3PO ligand using the Smina/Vinardo (red) and docking of the native ligand F-2,6-BP using the Autodock 4 (green). The 3PO binds to the 2-Pase domain, same as the F-2,6-BP native ligand, indicating why it inhibits the PFKFB3. The 2-Pase domain is shown in the cyan color, where the 2-Kase domain is shown in brick color. B) Amino acids within 3Å of the 3PO docked ligand. The number near the amino acid's name indicates a position in the protein structure. The two amino acids at the back of the image are glutamine 322 and isoleucine 323. C) Amino acids, that are shared between the docked 3PO ligand and the docked F-2,6-BP native ligand. The amino acids are shown within 3Å of both ligands.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Cytotoxic effect of 3PO on A375 melanoma cells: A) Viability of A375 cells after 24 and 48 h of incubation with 3PO measured using the MTT assay. B) Morphology of the A375 melanoma cells incubated in medium without (Ctrl) or with 3PO at a concentration of 5, 25 and 100 μM. C) Morphology of the A375 melanoma cell line incubated in medium alone (Ctrl) or medium with 3PO at a concentration of 5, 25 and 100 μM. The pictures and 3D representations were acquired using the holotomography microscope (3D Cell Explorer, Nanolive). *p<0.05. Scale bars: 200 μm. INH: Inhibition.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Cell death evaluation of A375 cells after 24 h of incubation without 3PO (Ctrl) and with 3PO at the concentration of 5, 25 and 100 μM (staining with Annexin-FITC and PI).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Apoptosis intensity after 24h incubation with 3PO. The representative microscopy images present cytoplasmatic expression of caspase 3 and 8 in A375 melanoma cells. The IHC reaction is stronger in cells exposed to the higher 3PO concentrations. Scale bars: 100 μM.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    The glucose uptake in A375 cell line after 24 h of incubation with 3PO. *p<0.05, **p<0.01, ****p<0.0001 compared to control. RLU: Relative luminescence units.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Clone formation efficacy in A375 cell line after 24 h of incubation with 3PO. **p<0.01 compared to control.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Cell cycle analysis of A375 cells presented as histograms of PI intensity staining after 24 h of incubation with different 3PO concentrations and its summary (bottom right graph).

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
  • Table IV.
PreviousNext
Back to top

In this issue

Anticancer Research: 40 (5)
Anticancer Research
Vol. 40, Issue 5
May 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells
KRZYSZTOF KOTOWSKI, STANISŁAW SUPPLITT, DANIEL WICZEW, DAWID PRZYSTUPSKI, WERONIKA BARTOSIK, JOLANTA SACZKO, JOANNA ROSSOWSKA, MAŁGORZATA DRĄG-ZALESIŃSKA, OLGA MICHEL, JULITA KULBACKA
Anticancer Research May 2020, 40 (5) 2613-2625; DOI: 10.21873/anticanres.14232

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
3PO as a Selective Inhibitor of 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 in A375 Human Melanoma Cells
KRZYSZTOF KOTOWSKI, STANISŁAW SUPPLITT, DANIEL WICZEW, DAWID PRZYSTUPSKI, WERONIKA BARTOSIK, JOLANTA SACZKO, JOANNA ROSSOWSKA, MAŁGORZATA DRĄG-ZALESIŃSKA, OLGA MICHEL, JULITA KULBACKA
Anticancer Research May 2020, 40 (5) 2613-2625; DOI: 10.21873/anticanres.14232
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 5-Azacytidine (5-aza) Induces p53-associated Cell Death Through Inhibition of DNA Methyltransferase Activity in Hep3B and HT-29 Cells
  • Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma
  • Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway
Show more Experimental Studies

Similar Articles

Keywords

  • Melanoma
  • BRAFV600E
  • 3PO
  • A375
  • inhibitor
  • PFKFB3
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire